packageDenosumab

denosumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Denosumab is a monoclonal antibody used to treat bone diseases, especially postmenopausal osteoporosis and bone loss linked to cancer. It is widely used and authorised in the European Union, with products covering osteoporosis, bone resorption, bone tumours, and giant cell tumour of bone.

Summary written by glm-5.3-flash from Wikidata Q408283 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:denosumab
ATC codes:M05BX04
DrugBank:DB06643
Wikidata:Q408283
molar mass:144700 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown